Researchers at the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR*) in Catania, Italy have just published a groundbreaking study.
It shows that smokers with chronic obstructive pulmonary disease (COPD) who switched to vaping reduced their yearly flare-ups by about 50 percent, significantly improved their cardio-respiratory health, and increased both their ability to exercise and their quality of life.
The study, led by CoEHAR founder Dr. Riccardo Polosa, is vitally important because COPD, to which emphysema and chronic bronchitis commonly contribute, is devastating. It makes breathing difficult and causes symptoms of wheezing, fatigue, shortness of breath, and a chronic cough. Many patients end up on long-term, portable oxygen therapy as symptoms worsen. Smoking tobacco is the main cause of COPD and almost 15.7 million Americans have been diagnosed with the disease.
The study compiled complete data over a five-year period for 39 participants—19 in the COPD smokers control group and 20 in the COPD e-cigarette user group. The vaping group used a variety of e-cigarettes, with a significant number switching from basic refillable e-cigs to more advanced devices during the study period.
Helen Redmond – FilterMag – November 9, 2020.
Want More Investigative Content?
